Skip to main content

Author: Customer Service

ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026

Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79% strict CR at abstract submission cut-off Positive updated data from iadademstat in relapsed/refractory FLT3-mut AML also accepted at EHA, showing 67% CRc Ongoing broad expansion of iadademstat clinical development across hematological malignancies, solid tumors and non-malignant hematology Active preparations underway for FDA protocol resubmission of the PORTICO-2 Phase III trial with vafidemstat in aggression in BPD Continued advancement of vafidemstat programs in schizophrenia and autism spectrum disorder Continued strengthening of IP protection for iadademstat and vafidemstat Strong cash position at the quarter ended March 2026: $25.4 million (€22.1 million)MADRID and CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE)...

Continue reading

Admission to Trading

LEI: 213800ZBKL9BHSL2K459 14 May 2026 OSB GROUP PLC (the Company) Notification of admission to trading The Company announced today the following information in accordance with The Public Offers and Admission to Trading Regulations 2024 (POATRs) PRM 1.6.4R.Details of issuer      (A)   Name OSB Group plc      (B)   LEI 213800ZBKL9BHSL2K459   Details of the transferable securities admitted to trading      (A)   Name, type and identification code Ordinary shares of £0.01 eachGB00BLDRH360      (B)   Regulated Market London Stock Exchange Main Market      (C)   Number of further securities issued and admitted 2,038,162      (D)   Total number of securities in issue following admission 347,296,004(2,141,504 ordinary shares (not yet in issue) remain subject to the block admission).      (E)   Fungibility Fully...

Continue reading

Saputo Inc.: Fiscal 2026 Fourth Quarter and Year-End Results

MONTRÉAL, May 14, 2026 (GLOBE NEWSWIRE) — Saputo will release its fiscal 2026 fourth quarter and full-year financial results on Thursday, June 4, 2026. A press release will be issued after markets close, and a conference call is scheduled on Friday, June 5, 2026, at 8:30 a.m. (Eastern Time) to discuss the Company’s results. The speakers will be Mr. Carl Colizza, President and CEO, and Mr. Maxime Therrien, CFO and Secretary. To participate:Webcast: A live webcast of the event can be accessed using this link.Presentation slides will be included in the webcast and can also be accessed in the “Investors” section of Saputo’s website (www.saputo.com), under “Calendar of Events”.Conference line: 1-800-715-9871; Conference ID: 5005277Please dial in five minutes before the call.Replay of the conference call and webcast presentationFor...

Continue reading

BluSky AI Inc. Announces Launch of Regulation A+ Offering to Accelerate U.S. AI Infrastructure Expansion

Salt Lake City Utah, May 14, 2026 (GLOBE NEWSWIRE) — BluSky AI Inc., a next-generation AI infrastructure company architecting a distributed neocloud network purpose-built for large-scale model training and inference computing, today announced the launch of its Regulation A+ offering. This new investment campaign is designed to enable individual and accredited investors to participate in the expansion of BluSky AI’s national modular AI Factory footprint with a minimum investment of $1,000. Investors can review offering materials and participate at: https://invest.bluskyaidatacenters.com/ BluSky AI is actively developing a distributed network of 10+ AI Factory sites across the United States, representing a potential capacity of over 200 MW dedicated to high-performance AI compute. These sites are being designed as part of BluSky...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 13 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 13 05 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

21shares Launches TKNS, Its First Actively Managed Crypto ETF, Bringing Dynamic Digital Asset Exposure to U.S. Investors

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) — 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced the launch of the 21shares Active Crypto ETF (Ticker: TKNS), marking the firm’s first actively managed cryptocurrency ETF in the United States. TKNS begins trading today and marks an expansion in 21shares’ product evolution from passive crypto ETFs to actively managed digital asset strategies.Ticker ISIN Exchange Currency Gross Expense Ratio Inception Date IssuerTKNS US53656H7448 NASDAQ USD 1.05% May 14th, 2026 21Shares US LLCTKNS seeks total return by investing, under normal circumstances, at least 80% of its net assets in crypto assets or crypto asset-related investments. The strategy blends Bitcoin’s structural role as a core portfolio asset with research-driven allocation across...

Continue reading

Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer

Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS mutation, supporting potential future evaluation alongside anti-PD-1 therapies including pembrolizumab (Keytruda®) Grand Cayman, Cayman Islands, May 14, 2026 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced positive preclinical findings from an ongoing translational immuno-oncology study evaluating its lead candidate, SIL204, in human KRAS-mutated pancreatic cancer cells. The study demonstrated a statistically significant increase...

Continue reading

APWC Announces Financial Results for the First Quarter of 2026

Quarterly revenue of $130.8 million, up 30% from a year ago Quarterly EPS was $0.05, up 171% from a year agoTAIPEI, Taiwan, May 14, 2026 (GLOBE NEWSWIRE) — Asia Pacific Wire & Cable Corporation Limited (“APWC” or the “Company”) (NASDAQ: APWC) today announced its financial results for the first quarter ended March 31, 2026. Quarterly revenue was $130.8 million, down 2% from the previous quarter and up 30% from a year ago. For the quarter, earnings per share were $0.05, down 71% from the previous quarter and up 171% from a year ago. Copper unit volume, measured by the tonnage of copper contained in the wire and cable sold, decreased 2% sequentially and increased 5% from a year ago. This does not include other raw materials, such as aluminum and insulation materials. Q1 Fiscal 2026 SummaryQ1 Financial...

Continue reading

Where Food Comes From, Inc. Reports 2026 First Quarter Financial Results

First Quarter Highlights – 2026 vs. 2025Verification and certification revenue increased to $4.4 million from $4.2 million Product sales increased slightly to $713,000 from $702,000 Total revenue increased to $5.4 million from $5.3 million Net income of $92,000, or $0.02 per share, up from $31,000, or $0.01 per share Company bought back 24,469 shares of its common stock at a cost of $293,000 Total buybacks since plan inception (including private purchases): 1,399,121 shares at a cost of approximately $15.5 millionCASTLE ROCK, Colo., May 14, 2026 (GLOBE NEWSWIRE) — Where Food Comes From, Inc. (WFCF) (Nasdaq: WFCF), the most trusted resource for independent, third-party verification of food production practices in North America, today announced financial results for its first quarter ended March 31, 2026. “We are pleased with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.